DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

BioTime, Inc. (NYSEMKT: BTX)

4.68 0.04 (0.86%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BTX $4.68 0.86%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.66
Previous Close $4.64
Daily Range $4.46 - $4.77
52-Week Range $2.33 - $5.95
Market Cap $389.7M
P/E Ratio -8.59
Dividend (Yield) $0.00 (0.0%)
Volume 668,664
Average Daily Volume 392,383
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

BioTime, Inc. (BTX) Description

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use. Website: http://www.biotimeinc.com/

News & Commentary

The Small-Cap Stock I'm Watching in 2015

Three Motley Fools tell investors which small-cap stocks they'll be watching in 2015.

Asterias Biotherapeutics' Stem Cell Program Is Dead On Arrival

BioTime's Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM

BioTime's Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM-Funded Preclinical Studies of Huntington's Disease

Thursday Sector Leaders: Biotechnology, Drugs

How Apple ResearchKit Could Change Science Forever

Asterias Biotherapeutics Announces Public Offering of Common Stock

BioTime, Inc.: Following The Smart Money

BioTime, Inc. Subsidiary OncoCyte Corporation Completes Initial Enrollment of Clinical Study of Urin

BioTime, Inc. Subsidiary OncoCyte Corporation Completes Initial Enrollment of Clinical Study of Urine-Based Bladder Cancer Diagnostic

UPDATE: BioTime Appoints Angus C. Russell To Bd Of Directors

Commit To Purchase BioTime At $2.50, Earn 14.5% Annualized Using Options

See More BTX News...

BTX's Top Competitors

BTX $4.68 (0.86%)
Current stock: BTX
GILD $112.27 (-0.51%)
Current stock: GILD
CELG $114.44 (-0.43%)
Current stock: CELG
BIIB $396.99 (-0.78%)
Current stock: BIIB